Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People’s Republic of China and internationally. The company offers Golden Throat Lozenges, an over-the-counter medicine to relieve symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat Lozenge series products, which include Dule Lozenges; sugar-free Dule Lozenges; and other sugar free flavours, such as orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn. In addition, the company offers Yinxingye tablets to facilitate blood circulation, remove blood stasis, and dredge energy channels; Golden Throat intestinal series for probiotics; and Golden Throat Compound Probiotic Lozenges. It exports its products to approximately 60 countries and regions. Golden Throat Holdings Group Company Limited was founded in 1956 and is headquartered in Liuzhou, the People’s Republic of China.
Metrics to compare | 6896 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6896PeersSector | |
---|---|---|---|---|
P/E Ratio | 10.4x | 36.4x | 12.2x | |
PEG Ratio | 0.38 | −0.68 | 0.03 | |
Price/Book | 2.3x | 2.6x | 1.5x | |
Price / LTM Sales | 2.8x | 3.3x | 0.9x | |
Upside (Analyst Target) | - | 6.0% | 16.8% | |
Fair Value Upside | Unlock | 11.8% | 10.5% | Unlock |